Ernest Belmonte

1.2k total citations · 1 hit paper
18 papers, 342 citations indexed

About

Ernest Belmonte is a scholar working on Epidemiology, Hepatology and Oncology. According to data from OpenAlex, Ernest Belmonte has authored 18 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 13 papers in Hepatology and 4 papers in Oncology. Recurrent topics in Ernest Belmonte's work include Hepatocellular Carcinoma Treatment and Prognosis (11 papers), Liver Disease Diagnosis and Treatment (11 papers) and Liver Disease and Transplantation (5 papers). Ernest Belmonte is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (11 papers), Liver Disease Diagnosis and Treatment (11 papers) and Liver Disease and Transplantation (5 papers). Ernest Belmonte collaborates with scholars based in Spain, Lebanon and United Kingdom. Ernest Belmonte's co-authors include Anna Darnell, Ángeles García‐Criado, Jordi Bruix, Jordi Rimola, Carmen Ayuso, R. Vilana, Marta Burrel, Luís Bianchi, C. Brú and Marta Barrufet and has published in prestigious journals such as Journal of Hepatology, European Radiology and Cancers.

In The Last Decade

Ernest Belmonte

16 papers receiving 339 citations

Hit Papers

Diagnosis and staging of hepatocellular carcinoma (HCC): ... 2018 2026 2020 2023 2018 50 100 150 200 250

Peers

Ernest Belmonte
Sui Peng China
Denise N. Gansen United States
Poh Seng Tan Singapore
P Hilgard Germany
Sui Peng China
Ernest Belmonte
Citations per year, relative to Ernest Belmonte Ernest Belmonte (= 1×) peers Sui Peng

Countries citing papers authored by Ernest Belmonte

Since Specialization
Citations

This map shows the geographic impact of Ernest Belmonte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ernest Belmonte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ernest Belmonte more than expected).

Fields of papers citing papers by Ernest Belmonte

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ernest Belmonte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ernest Belmonte. The network helps show where Ernest Belmonte may publish in the future.

Co-authorship network of co-authors of Ernest Belmonte

This figure shows the co-authorship network connecting the top 25 collaborators of Ernest Belmonte. A scholar is included among the top collaborators of Ernest Belmonte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ernest Belmonte. Ernest Belmonte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Lens, Sabela, Laura J. Pallett, Ernest Belmonte, et al.. (2025). HBV Suppression by Nucleos(t)ide Analogues Reduces PD ‐1 Expression on Liver‐Resident T Cells. Liver International. 45(11). e70338–e70338. 1 indexed citations
2.
Arcari, Luca, Giacomo Tini, Giovanni Camastra, et al.. (2024). Clinical characteristics and outcomes of Takotsubo syndrome in patients with chronic obstructive pulmonary disease. European Journal of Internal Medicine. 132. 84–89. 2 indexed citations
3.
Arcari, Luca, Giovanni Camastra, Federica Ciolina, et al.. (2024). Cardiac magnetic resonance in patients with Takotsubo syndrome: Clinical correlates of T2 mapping. International Journal of Cardiology. 419. 132716–132716. 3 indexed citations
4.
Muñoz, Sergio, Víctor Sapena, Ángeles García‐Criado, et al.. (2023). Risk of Treatment Failure and Death after Ablation in Hepatocellular Carcinoma Patients—A Multiparametric Prediction. Cancers. 15(13). 3269–3269. 3 indexed citations
5.
García‐Criado, Ángeles, Jordi Rimola, Susana Seijó, et al.. (2023). MRI Using Gadoxetic Acid in the Work-Up of Liver Nodules Not Conclusively Benign in Budd-Chiari Syndrome: A Prospective Long-Term Follow-Up. Liver Cancer. 13(2). 203–214.
6.
Mandorfer, Mattias, Fanny Turón, Sabela Lens, et al.. (2021). Risk of non‐tumoural portal vein thrombosis in patients with HCV‐induced cirrhosis after sustained virological response. Liver International. 41(12). 2954–2964. 5 indexed citations
7.
Darnell, Anna, Jordi Rimola, Ernest Belmonte, et al.. (2021). Evaluation of LI-RADS 3 category by magnetic resonance in US-detected nodules ≤ 2 cm in cirrhotic patients. European Radiology. 31(7). 4794–4803. 10 indexed citations
9.
Díaz‐González, Álvaro, Víctor Sapena, Loreto Boix, et al.. (2021). Early diarrhoea under sorafenib as a marker to consider the early migration to second‐line drugs. United European Gastroenterology Journal. 9(6). 655–661. 1 indexed citations
10.
Magaz, Marta, Alberto Álvarez‐Larrán, Dolors Colomer, et al.. (2020). Next-generation sequencing in the diagnosis of non-cirrhotic splanchnic vein thrombosis. Journal of Hepatology. 74(1). 89–95. 23 indexed citations
11.
Rimola, Jordi, Anna Darnell, Ernest Belmonte, et al.. (2020). Does transient arterial-phase respiratory-motion-related artifact impact on diagnostic performance? An intra-patient comparison of extracellular gadolinium versus gadoxetic acid. European Radiology. 30(12). 6694–6701. 10 indexed citations
12.
Díaz‐González, Álvaro, Víctor Sapena, Loreto Boix, et al.. (2020). Pharmacokinetics and pharmacogenetics of sorafenib in patients with hepatocellular carcinoma: Implications for combination trials. Liver International. 40(10). 2476–2488. 9 indexed citations
13.
Burrel, Marta, Anna Darnell, Víctor Sapena, et al.. (2020). The “six-and-twelve” score in a prospective cohort of patients with hepatocellular carcinoma treated with trans-arterial chemoembolization following a fixed schedule. Journal of Hepatology. 73. S907–S907. 2 indexed citations
14.
Díaz‐González, Álvaro, Ernest Belmonte, Víctor Sapena, et al.. (2020). Pancreatic Insufficiency in Patients Under Sorafenib Treatment for Hepatocellular Carcinoma. Journal of Clinical Gastroenterology. 55(3). 263–270. 5 indexed citations
15.
Forner, Alejandro, Anna Darnell, Jordi Rimola, et al.. (2019). PS-115-Evaluation of LI-RADS v2018 by magnetic resonance in US-detected nodules < 2 cm in cirrhotics. Journal of Hepatology. 70(1). e73–e73. 2 indexed citations
16.
Ayuso, Carmen, Jordi Rimola, R. Vilana, et al.. (2018). Diagnosis and staging of hepatocellular carcinoma (HCC): current guidelines. European Journal of Radiology. 101. 72–81. 262 indexed citations breakdown →
17.
Sapena, Víctor, Álvaro Díaz‐González, Anna Darnell, et al.. (2018). Impact of regorafenib in the clinical practice and identification of second-line treatment orphan patients. Journal of Hepatology. 68. S205–S206. 1 indexed citations
18.
Reig, María, Loreto Boix, Ferràn Torres, et al.. (2018). Towards personalised approach in systemic treatment for hepatocellular carcinoma. The value of AGT M235T gene polymorphism. Journal of Hepatology. 68. S197–S197. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026